136 related articles for article (PubMed ID: 36343693)
1. Phenotypic screening identifies hydroxypyridone anti-fungals as novel medicines for the prevention of hypertrophic scars.
Lapthorn AR; Ilg MM; Sullivan JV; Dziewulski P; Cellek S
Eur J Pharmacol; 2022 Dec; 937():175374. PubMed ID: 36343693
[TBL] [Abstract][Full Text] [Related]
2. Hydroxypyridone anti-fungals selectively induce myofibroblast apoptosis in an in vitro model of hypertrophic scars.
Lapthorn AR; Ilg MM; Dziewulski P; Cellek S
Eur J Pharmacol; 2024 Mar; 967():176369. PubMed ID: 38325796
[TBL] [Abstract][Full Text] [Related]
3. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Wells AR; Leung KP
Biochem Biophys Res Commun; 2020 Jan; 521(3):646-651. PubMed ID: 31679692
[TBL] [Abstract][Full Text] [Related]
5. LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts.
Wei G; Xu Q; Liu L; Zhang H; Tan X; Zhang C; Han C; Guo Y; Han G; Zhang C
Arch Dermatol Res; 2018 Oct; 310(8):615-623. PubMed ID: 30046895
[TBL] [Abstract][Full Text] [Related]
6. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
7. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
8. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
9. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
10. Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop.
Dabiri G; Tumbarello DA; Turner CE; Van de Water L
J Invest Dermatol; 2008 Oct; 128(10):2518-25. PubMed ID: 18401422
[TBL] [Abstract][Full Text] [Related]
11. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
12. miR-145 Contributes to Hypertrophic Scarring of the Skin by Inducing Myofibroblast Activity.
Gras C; Ratuszny D; Hadamitzky C; Zhang H; Blasczyk R; Figueiredo C
Mol Med; 2015 Apr; 21(1):296-304. PubMed ID: 25876136
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model.
Hu CH; Tseng YW; Chiou CY; Lan KC; Chou CH; Tai CS; Huang HD; Hu CW; Liao KH; Chuang SS; Yang JY; Lee OK
Stem Cell Res Ther; 2019 Aug; 10(1):275. PubMed ID: 31462299
[TBL] [Abstract][Full Text] [Related]
14. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway.
Ji X; Tang Z; Shuai W; Zhang Z; Li J; Chen L; Cao J; Yin W
Life Sci; 2019 Aug; 231():116674. PubMed ID: 31344427
[TBL] [Abstract][Full Text] [Related]
15. Regenerative potential of adipocytes in hypertrophic scars is mediated by myofibroblast reprogramming.
Hoerst K; van den Broek L; Sachse C; Klein O; von Fritschen U; Gibbs S; Hedtrich S
J Mol Med (Berl); 2019 Jun; 97(6):761-775. PubMed ID: 30891616
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts.
Cho JS; Moon YM; Park IH; Um JY; Moon JH; Park SJ; Lee SH; Kang HJ; Lee HM
Clin Exp Allergy; 2012 Jun; 42(6):872-82. PubMed ID: 22239687
[TBL] [Abstract][Full Text] [Related]
17. Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children.
Zhang Z; Finnerty CC; He J; Herndon DN
Burns; 2012 Mar; 38(2):236-46. PubMed ID: 21920670
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing.
Goldberg MT; Han YP; Yan C; Shaw MC; Garner WL
J Invest Dermatol; 2007 Nov; 127(11):2645-55. PubMed ID: 17554369
[TBL] [Abstract][Full Text] [Related]
19. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
[TBL] [Abstract][Full Text] [Related]
20. SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
Sun GF; Li HC; Zhan YP; Zhang XF; Pan LY; Chen YF; Xu K; Feng DX
Lab Invest; 2019 Dec; 99(12):1861-1873. PubMed ID: 31409891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
